Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants with Vascular Disease (VERTIS-CV), which compared ertugliflozin with placebo showed non-inferiority in regards to its primary MACE outcome, as well as a 30% reduction in HHF [41]
Mounjaro has received significant attention because it works through two distinct hormone pathways involved in appetite and blood sugar regulation
[11] By ramping up the dosage slowly, patients can often avoid side effects like headache or nausea while still obtaining the energizing or cognitive benefits of NAD+
Prebiotic fibers from vegetables like garlic, onions, and asparagus feed beneficial bacteria throughout the gut
The researchers found that injection site pain scores were generally low across all sites, with no significant difference in patient comfort between the abdomen, thigh, and upper arm when proper technique was used
Individual weight loss goals : Some patients are stratified with minor weight loss changes and do not aim to lose a lot of weight
